The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
BackgroundPatients with triple-negative breast cancer (TNBC) have poor overall survival. The present study aimed to investigate the potential prognostics of TNBC by analyzing breast cancer proteomic and transcriptomic datasets.MethodsCandidate proteins selected from CPTAC (the National Cancer Instit...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa2062e4e0464395893493d2337d248b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:aa2062e4e0464395893493d2337d248b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:aa2062e4e0464395893493d2337d248b2021-11-15T05:20:51ZThe Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer2234-943X10.3389/fonc.2021.751430https://doaj.org/article/aa2062e4e0464395893493d2337d248b2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.751430/fullhttps://doaj.org/toc/2234-943XBackgroundPatients with triple-negative breast cancer (TNBC) have poor overall survival. The present study aimed to investigate the potential prognostics of TNBC by analyzing breast cancer proteomic and transcriptomic datasets.MethodsCandidate proteins selected from CPTAC (the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium) were validated using datasets from METABRIC (Molecular Taxonomy of Breast Cancer International Consortium). Kaplan-Meier analysis and ROC (receiver operating characteristic) curve analysis were performed to explore the prognosis of candidate genes. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis were performed on the suspected candidate genes. Single-cell RNA-seq (scRNA-seq) data from GSE118389 were used to analyze the cell clusters in which OBFC2A (Oligosaccharide-Binding Fold-Containing Protein 2A) was mainly distributed. TIMER (Tumor Immune Estimation Resource) was used to verify the correlation between OBFC2A expression and immune infiltration. Clone formation assays and wound healing assays were used to detect the role of OBFC2A expression on the proliferation, invasion, and migration of breast cancer cells. Flow cytometry was used to analyze the effects of silencing OBFC2A on breast cancer cell cycle and apoptosis.ResultsSix candidate proteins were found to be differentially expressed in non-TNBC and TNBC groups from CPTAC. However, only OBFC2A was identified as an independently poor prognostic gene marker in METABRIC (HR=3.658, 1.881-7.114). And OBFC2A was associated with immune functions in breast cancer. Biological functional experiments showed that OBFC2A might promote the proliferation and migration of breast cancer cells. The inhibition of OBFC2A expression blocked the cell cycle in G1 phase and inhibited the transformation from G1 phase to S phase. Finally, downregulation of OBFC2A also increased the total apoptosis rate of cells.ConclusionOn this basis, OBFC2A may be a potential prognostic biomarker for TNBC.Qianxue WuXin TangWenming ZhuQing LiXiang ZhangHongyuan LiFrontiers Media S.A.articleOBFC2Atriple-negative breast cancerprognosisoverall survivalmolecular biologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
OBFC2A triple-negative breast cancer prognosis overall survival molecular biology Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
OBFC2A triple-negative breast cancer prognosis overall survival molecular biology Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Qianxue Wu Xin Tang Wenming Zhu Qing Li Xiang Zhang Hongyuan Li The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer |
description |
BackgroundPatients with triple-negative breast cancer (TNBC) have poor overall survival. The present study aimed to investigate the potential prognostics of TNBC by analyzing breast cancer proteomic and transcriptomic datasets.MethodsCandidate proteins selected from CPTAC (the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium) were validated using datasets from METABRIC (Molecular Taxonomy of Breast Cancer International Consortium). Kaplan-Meier analysis and ROC (receiver operating characteristic) curve analysis were performed to explore the prognosis of candidate genes. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis were performed on the suspected candidate genes. Single-cell RNA-seq (scRNA-seq) data from GSE118389 were used to analyze the cell clusters in which OBFC2A (Oligosaccharide-Binding Fold-Containing Protein 2A) was mainly distributed. TIMER (Tumor Immune Estimation Resource) was used to verify the correlation between OBFC2A expression and immune infiltration. Clone formation assays and wound healing assays were used to detect the role of OBFC2A expression on the proliferation, invasion, and migration of breast cancer cells. Flow cytometry was used to analyze the effects of silencing OBFC2A on breast cancer cell cycle and apoptosis.ResultsSix candidate proteins were found to be differentially expressed in non-TNBC and TNBC groups from CPTAC. However, only OBFC2A was identified as an independently poor prognostic gene marker in METABRIC (HR=3.658, 1.881-7.114). And OBFC2A was associated with immune functions in breast cancer. Biological functional experiments showed that OBFC2A might promote the proliferation and migration of breast cancer cells. The inhibition of OBFC2A expression blocked the cell cycle in G1 phase and inhibited the transformation from G1 phase to S phase. Finally, downregulation of OBFC2A also increased the total apoptosis rate of cells.ConclusionOn this basis, OBFC2A may be a potential prognostic biomarker for TNBC. |
format |
article |
author |
Qianxue Wu Xin Tang Wenming Zhu Qing Li Xiang Zhang Hongyuan Li |
author_facet |
Qianxue Wu Xin Tang Wenming Zhu Qing Li Xiang Zhang Hongyuan Li |
author_sort |
Qianxue Wu |
title |
The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer |
title_short |
The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer |
title_full |
The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer |
title_fullStr |
The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer |
title_full_unstemmed |
The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer |
title_sort |
potential prognostic role of oligosaccharide-binding fold-containing protein 2a (obfc2a) in triple-negative breast cancer |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/aa2062e4e0464395893493d2337d248b |
work_keys_str_mv |
AT qianxuewu thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT xintang thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT wenmingzhu thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT qingli thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT xiangzhang thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT hongyuanli thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT qianxuewu potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT xintang potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT wenmingzhu potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT qingli potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT xiangzhang potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer AT hongyuanli potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer |
_version_ |
1718428635520565248 |